Illumineuro

Illumineuro peptide blend is a multi-compound research formulation composed of Pinealon, NA-Selank, NA-Semax, and PE-22-28. This Illumineuro peptide blend is designed for experimental work focused on neuropeptide signaling, neuroendocrine regulation, stress-response pathways, and cellular resilience within nervous system research models.

(Dolotov et al., 2006 — Journal of Neurochemistry).

Rather than acting through a single pathway, Illumineuro combines multiple short peptides commonly studied for their roles in neuronal communication, cognitive signaling, and adaptive stress mechanisms. Pinealon is a tripeptide bioregulator studied for its influence on pineal gland function and neuroprotective signaling. NA-Selank and NA-Semax are acetylated analogues of their parent compounds, offering enhanced enzymatic stability while preserving their neuromodulatory characteristics (Semenova et al., 2008 — Bulletin of Experimental Biology and Medicine).

PE-22-28 is a synthetic analogue of spadin, a peptide derived from the TREK-1 potassium channel propeptide, investigated for its potential role in synaptic plasticity and mood-related signaling pathways. This multi-component approach allows researchers to explore complementary neurobiological processes within controlled laboratory environments (Mazella et al., 2018 — Frontiers in Pharmacology).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.